In January 2026, the IMDEA Food Institute hosted the consortium’s Kick-Off Meeting, establishing a multidisciplinary alliance set to revolutionize venom-based drug discovery.
Pioneering approach
This past January, Madrid became the vibrant hub of European toxinology. Leading experts in chemistry, biology, pharmacology, and translational research gathered at the IMDEA Food Institute for the official VENOVATE Kick-Off Meeting. This face-to-face encounter marked the official launch of the initiative, defining its organizational structure, business plan, and strategic roadmap in perfect alignment with the IG19144 action goals.
“Leading experts in chemistry, biology, pharmacology, and translational research gathered at the IMDEA Food Institute for the official VENOVATE Kick-Off Meeting”
Throughout the sessions, the consortium mapped out the core components of its research pipeline, from initial biodiscovery using omics data to final validation and successfully concluded with the launch of thematic working groups, which will maintain momentum through regular online follow-ups to track milestones and foster ongoing collaboration.
Pioneering approach
With this powerful start in Madrid, VENOVATE sets off on a highly collaborative journey, ready to deliver tangible impacts in biomedicine and healthcare. The journey has officially begun!
